NS-3-008 hydrochloride structure
|
Common Name | NS-3-008 hydrochloride | ||
---|---|---|---|---|
CAS Number | 1172854-54-4 | Molecular Weight | 269.817 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C14H24ClN3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of NS-3-008 hydrochlorideNS-3-008 is a novel small-molecule transcriptional inhibitor of G0s2 (G0/G1 switch 2) with IC50 of 2.25 uM; decreases levels of G0s2 and Ccl2 mRNA in the kidneys (5 mg/kg, p.o.); decreases the phosphorylation of Stat5 and p65 protein and suppresses renal inflammation in 5/6Nx mice, ameliorates renal dysfunction in mouse model of chronic kidney disease (CKD). |
Name | NS-3-008 |
---|
Description | NS-3-008 is a novel small-molecule transcriptional inhibitor of G0s2 (G0/G1 switch 2) with IC50 of 2.25 uM; decreases levels of G0s2 and Ccl2 mRNA in the kidneys (5 mg/kg, p.o.); decreases the phosphorylation of Stat5 and p65 protein and suppresses renal inflammation in 5/6Nx mice, ameliorates renal dysfunction in mouse model of chronic kidney disease (CKD). |
---|---|
Related Catalog | |
Target |
IC50: 2.25 μM (G0s2)[1] |
In Vitro | NS-3-008 binds to Hsd17b4; knockdown of Hsd17b4 decreased G0s2 mRNA levels, whereas overexpression of Hsd17b4 induced G0s2 mRNA expression. The inhibitory effects of NS-3-008 are blocked by knockdown of Hsd17b4 or deletion of the Stat5 binding site in the G0s2 promoter. NS-3-008 decreases the nuclear phosphorylation of Stat5[1]. |
In Vivo | NS-3-008 (5 mg/kg; oral administration; daily; for 4 weeks; wild-type 5/6Nx mice) treatment results in decreased levels of G0s2 and Ccl2 mRNA in the kidneys. The phosphorylation of Stat5 and p65 protein is decreased, and SUN concentrations and renal caspase 3/7 activity decreased in 5/6Nx mice treated with NS-03-08. The F4/80-positive area and F4/80 protein levels are decreased in 5/6Nx mice treated with NS-3-008[1]. |
References |
Molecular Formula | C14H24ClN3 |
---|---|
Molecular Weight | 269.817 |
Storage condition | 2-8℃ |